Search results
Study reports new compound that halts replication of COVID by targeting 'Mac-1' protein in cell...
Medical Xpress· 12 hours agoResearch appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the...
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
Investing.com· 1 week agoLungs of young adults more susceptible to SARS-CoV-2 virus: Study
Physicist Studying SARS-CoV-2 Virus Believes He Has Found Hints We Are Living In A Simulation
IFLScience· 1 week agoA physicist studying mutations of the SARS-CoV-2 virus claims to have found evidence for a new law...
Stanford Medicine Unmasks the Surprising Instigators of Severe COVID in the Lungs
SciTechDaily· 1 week agoA previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 10 hours agoThe scientists investigated the antibody neutralization response against different variants of SARS-...
New technology uncovers mechanism affecting generation of new COVID variants
Medical Xpress· 4 days agoUnderstanding the genetic mechanism fueling SARS-CoV-2's ability to generate variants can go a long way in keeping COVID at bay. In a ...
Researchers find no link between COVID-19 virus and development of asthma in children
Medical Xpress· 2 weeks agoNow, researchers from Children's Hospital of Philadelphia (CHOP) found that a SARS-COV-2 infection...
JN.1 COVID Variant Symptoms vs. Allergy Symptoms
Verywell Health via Yahoo News· 4 days agoThe JN.1 COVID variant has slightly different symptoms than other variants, as well as some differences when compared to seasonal allergies. Here's what...
How B cells recognize new variants of SARS-CoV-2
Medical Xpress· 3 days agoResearchers at TWINCORE, Center for Clinical and Experimental Infection Research, have now been able to show that the combination of infection and...
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 3 days agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people